powered by
▸
healthparse
Search
Cohort Builder
Tools
▾
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
▾
By state
By specialty
Pricing
Search
Cohort Builder
Tools
KOL Finder
Territories
Drug Compare
AI Query
Research
Browse
By state
By specialty
Pricing
PROVIDER PROFILE · NPI 1295129492
Vaughn Eyvazian
M.D.
Internal Medicine
Los Angeles,
CA
I
CROSS-REFERENCE
Related data on other Healthparse brands
ProviderScore
OIG/SAM exclusion screening, sanctions history
QUALITY · MIPS · 2024
Final MIPS score
88.5
Quality
79.2
Cost
68.6
Improvement activities
40.0
Promoting interop.
96.0
Payment adjustment
0.57%
Group
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (4)
CCN 050082
Hospital
CCN 050236
Hospital
CCN 050262
Hospital
CCN 050549
Hospital
PRESCRIBING · PART D · 2024
Total Rx claims
1,272
Beneficiaries
—
Total drug cost
$370K
Distinct drugs
22
Brand share
32.3%
Top prescribed drugs
Atorvastatin Calcium
146 claims
Metoprolol Succinate
135 claims
Amlodipine Besylate
116 claims
Rosuvastatin Calcium
88 claims
Furosemide
80 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$4K
Payment records
141
By payment type
Food and Beverage
$3K
Travel and Lodging
$654
Top paying entities
Food and Beverage
$3K
Travel and Lodging
$654
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
4,128
Unique beneficiaries
—
Total services
12,276
Distinct HCPCS
43
Medicare payment
$1.0M
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 10,499 Internal Medicine providers in CA — top quintile (cohort median 531).